Osteonecrosis due to drugs, humerus
ICD-10 M87.12 is a billable code used to indicate a diagnosis of osteonecrosis due to drugs, humerus.
Osteonecrosis due to drugs, specifically affecting the humerus, is a condition characterized by the death of bone tissue due to a lack of blood supply, often as a result of pharmacological agents. This condition can arise from the use of corticosteroids, bisphosphonates, or other medications that may compromise blood flow to the bone. Patients may present with pain in the shoulder region, limited range of motion, and potential joint dysfunction. The humerus, being a critical bone in the shoulder girdle, is particularly susceptible to osteonecrosis, leading to significant orthopedic complications such as joint instability and arthritis. Diagnosis typically involves imaging studies such as MRI or X-rays, which can reveal changes in bone density and structure. Early detection is crucial to prevent further deterioration and to manage symptoms effectively. Treatment options may include medication adjustments, physical therapy, or surgical interventions such as joint replacement in severe cases.
Detailed history of medication use, imaging results, and clinical findings.
Patients presenting with shoulder pain and a history of corticosteroid use.
Ensure that the documentation clearly links the drug use to the osteonecrosis diagnosis.
Comprehensive medication history and assessment of joint function.
Patients with autoimmune disorders on long-term steroid therapy developing shoulder pain.
Document the rationale for medication use and any changes in therapy.
Used for pain management in patients with osteonecrosis.
Document the indication for the procedure and the patient's response.
Orthopedic specialists should ensure that the procedure is justified based on clinical findings.
Common medications include corticosteroids, bisphosphonates, and certain chemotherapy agents. It is essential to document any relevant medication history when coding.
